Zydol-P DS Suspension is a combination analgesic formulation containing Mefenamic Acid 100 mg and Paracetamol 250 mg per dose, designed for the effective management of mild to moderate pain and inflammation. Mefenamic Acid, a nonsteroidal anti-inflammatory drug (NSAID), exerts its therapeutic effect by inhibiting cyclooxygenase enzymes, thereby reducing the synthesis of prostaglandins responsible for pain and inflammation. Paracetamol, an analgesic and antipyretic agent, provides additional pain relief and fever reduction through central inhibition of prostaglandin synthesis. The synergistic action of these two active ingredients makes Zydol-P DS Suspension suitable for conditions such as musculoskeletal pain, dental pain, dysmenorrhea, and febrile states. The suspension form facilitates ease of administration, particularly in pediatric and geriatric populations or patients with swallowing difficulties. Zydol-P DS Suspension should be used under medical supervision, adhering to recommended dosages to minimize potential adverse effects such as gastrointestinal irritation, hepatotoxicity, or hypersensitivity reactions. Caution is advised in patients with pre-existing liver or kidney impairment, peptic ulcer disease, or known hypersensitivity to NSAIDs or paracetamol. Regular monitoring and consultation with a healthcare professional are recommended during prolonged therapy to ensure safety and efficacy.